Excimer Laser Trabeculostomy Glaucoma Treatment Study | MicrobiomeTrials← Back to trialsNCT04899063
Excimer Laser Trabeculostomy Glaucoma Treatment Study
CompletedNAINTERVENTIONAL
Trial Details
Start: 2021-05-10Est. Completion: 2025-07-29
Enrollment target: 318 participants Locations- ELIOS Vision Clinical Site, Glendale, Arizona, United States
- ELIOS Vision Clinical Site, Petaluma, California, United States
- ELIOS Vision Clinical Site, Fort Collins, Colorado, United States
- ELIOS Vision Clinical Site, Grand Junction, Colorado, United States
- ELIOS Vision Clinical Site, DeLand, Florida, United States
- ELIOS Vision Clinical Site, Largo, Florida, United States
- ELIOS Vision Clinical Site, Melbourne, Florida, United States
- ELIOS Vision Clinical Site, Vero Beach, Florida, United States
- ELIOS Vision Clinical Site, Rock Island, Illinois, United States
- ELIOS Vision Clinical Site, Overland Park, Kansas, United States
- ELIOS Vision Clinical Site, Chaska, Minnesota, United States
- ELIOS Vision Clinical Site, St Louis, Missouri, United States
- ELIOS Vision Clinical Site, Las Vegas, Nevada, United States
- ELIOS Vision Clinical Site, South Orange, New Jersey, United States
- ELIOS Vision Clinical Site, Oklahoma City, Oklahoma, United States
- ELIOS Vision Clinical Site, Duncanville, Texas, United States
- ELIOS Vision Clinical Site, El Paso, Texas, United States
- Elios Vision Clinical Site 2, San Antonio, Texas, United States
- ELIOS Vision Clinical Site, San Antonio, Texas, United States
- ELIOS Vision Clinical Site, Kenosha, Wisconsin, United States
Other microbiome trials you might be interested in
Glaucoma, Primary Open Angle
Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult s…
Glendale, United StatesCompleted Apr 28, 2026
POAGMIGS
Primary open-angle glaucoma (POAG) is a chronic eye disease in which the only validated treatment is to lower intraocula…
Amiens, FranceEst. completion Jun 2026